Well, IDE integrations are completely different stuff... What IDE do you use? Can I recommend you to try it out in Terminal instead?
T On Mon, Dec 18, 2023 at 11:18 PM <mark.yagnatin...@barclays.com.invalid> wrote: > Thanks! Just tried in my IDE and it failed, but not sure if that's an > issue with maven or with IDE. > (I have a multi-module project and it tried to download the submodules > instead of using the local source code) > > -----Original Message----- > From: Tamás Cservenák <ta...@cservenak.net> > Sent: Monday, December 18, 2023 5:08 PM > To: Maven Users List <users@maven.apache.org> > Cc: subharaj.ma...@gmail.com > Subject: Re: Maven 4.0 release timeline > > > CAUTION: This email originated from outside our organisation - > ta...@cservenak.net Do not click on links, open attachments, or respond > unless you recognize the sender and can validate the content is safe. > Howdy, > > And to reply to the "longer stuff": > > Current Maven 4 (on vote, so 3 days if vote passes OK and files land on > Central) is alpha-10. > > As with any previous alphas, the _minimal_ requirement is that UT passes, > Maven can build itself, and that to pass Maven IT suite. IT suite is > currently, in this very moment 909 IT tests, but they grow constantly, as > new bugs or new features are added, this link > https://clicktime.symantec.com/15sM1Hx4Zk69FcT4Re31T?h=WCNYF5iZoo32qX5Hxyc8Qrzhc1t-HKpREAcWNL1r7t8=&u=https://github.com/apache/maven-integration-testing/pulse/monthly > shows there were 3 ITs added last, two bugs from alpha-9 and new feature > regarding plugin validation. > > As a downer, Maven 4 alpha-11 is FOR SURE expected, already scheduled: > > https://clicktime.symantec.com/15sMAxLdUyTL5W6uWkqJh?h=KbxkwIqLoMQYfHx5OCZ4V-Mu7NdrW7MXjqNgyyl25so=&u=https://issues.apache.org/jira/issues/?jql%3Dproject%2520%253D%2520MNG%2520AND%2520fixVersion%2520%253D%25204.0.0-alpha-11 > > Currently we work on stabilizing resolver and maven (both are alphas!), > and ironing out the new Maven 4 API (thus converting MANY core plugins to > use new API), see here: > https://clicktime.symantec.com/15sM689M2MmjfZGyyCSA5?h=7_-nR2qTzP6RIZLBqH9pHMeQfYQjGw5njIatpLSW6_U=&u=https://github.com/apache/maven/pull/1048 > > Basically we make sure that the new API delivers _everything_ we need in > core plugins, and even more, as some information trickles from third party > plugins as well. We have to do this "intelligence" work in alpha, where we > can break APIs, as we really need to adjust, adapt and make sure all this > once is set in stone (released as final), will work out for everyone doing > plugin development. > > Good news is that Resolver 2.0.0 is pretty much "done": > > https://clicktime.symantec.com/15sMFnXuwb8vVSvq4KETK?h=djE-5RAYZwC_J0iiRHe3cw4LXST_S1deoAEfdJrJlfU=&u=https://issues.apache.org/jira/issues/?jql%3Dproject%2520%253D%2520MRESOLVER%2520AND%2520fixVersion%2520%253D%25202.0.0-alpha-6 > > I am not saying "resolver is done-done", just that we are "over the hill", > as regarding issue numbers over there. Most probably will have some lurking > bugs, like the last one was in Resolver 2 alpha-3 (plagues Maven 4 alpha-9) > about new "jdk" transport. And for sure will have bugs regarding new > transport features, as they are not ironed out fully. > > Maven core is completely different, especially due to its API. Hence, the > more (intel) we get the merrier, as we see "core plugins" only. > > So please try out, test it and report back. > > Thanks > T > > On Mon, Dec 18, 2023 at 9:39 PM <mark.yagnatin...@barclays.com.invalid> > wrote: > > > I'm not the original asker but this kind of answer tends to annoy me. > > Yes, there is no "official" release timeline, you're obviously not > > going to promise anything, all this is (hopefully?) clear, BUT! > > You no doubt have GUESSES. And your guesses are no doubt better than > > that of most uninformed outsiders. > > As an outsider, I have no idea what the "status" of maven 4 is, and I > > can't even begin to guess how I would find out. > > Should I try to catch up on the last few years of traffic on the > > developer email lists? > > Or perhaps the answer can be divined from the issue tracker? If so, how? > > Is it expected that alpha-10 will be the last alpha, and the next > > build will be a beta? > > If that is NOT what you expect, then what's the primary hold up? > > Are there major features that have yet to be implemented? > > Or perhaps the features are mostly done but they're still a bit buggy? > > Or perhaps the code quality is pretty solid and you just want to > > reserve the right to make backwards incompatible changes, and there's > > a policy to not do that after hitting beta? > > > > You get the idea. As an insider, you probably think to yourself > > "there's no telling when we'll be done; it depends on a zillion > > unpredictable things". > > But as outsiders, we don't even know whether the ETA is a few months > > or a few years or a few decades or perhaps just a few weeks. > > > > Sorry if that came off as a bit of a rant :) > > > > > > -----Original Message----- > > From: Karl Heinz Marbaise <khmarba...@gmx.de.INVALID> > > Sent: Monday, December 18, 2023 3:18 PM > > To: Maven Users List <users@maven.apache.org>; Debraj Manna < > > subharaj.ma...@gmail.com> > > Subject: Re: Maven 4.0 release timeline > > > > > > CAUTION: This email originated from outside our organisation - > > khmarba...@gmx.de.INVALID Do not click on links, open attachments, or > > respond unless you recognize the sender and can validate the content > > is safe. > > On 18.12.23 06:27, Debraj Manna wrote: > > > Can someone let me know when Maven 4 is expected to be released? > > > Where can I view its release timelines? > > > > > > > We are an open source project. We don't have a release timeline. > > > > Maven 4.0.0 will be there when it's there. > > > > > > If you want to help testing, there is 4.0.0-alpha-9 version available > > (at the moment the VOTE for 4.0.0-alpha-10 is running developers list).. > > > > > > > > https://clicktime.symantec.com/15t5ejZL3AGSyEFA9Aedx?h=ABJzOQGm-e1Zxyu > > IqUZPLWnHHC2LmzcP6V9UINAuTSc=&u=https://clicktime.symantec.com/15sMRSv > > UrpW7KLag9S2kZ?h=rxf-w5YKFX3JdAeLcUTmzKYQVnVeiOsR34J0KA2uXC0=&u=https: > > //maven.apache.org/download.cgi > > > > https://clicktime.symantec.com/15t5ZuN3aYarZHREbcFVL?h=f4YJm-aS7T_bpjO > > AtqB_jneksRphxbi0aG911AdXT1E=&u=https://clicktime.symantec.com/15sMLcj > > CQCpWuPkkbsdbw?h=vaqP1yibGHIYESRZVgj1tPm7fyADAiWggnAoeWY0YG4=&u=https: > > //maven.apache.org/docs/history.html > > > > https://clicktime.symantec.com/15t5jZkcVmx3PB55gj3na?h=L9e7tA5cT0v2zyk > > QUoinwwWFS6c1VuE5zuM7Lmb8XwE=&u=https://clicktime.symantec.com/15sMWH7 > > mKSBhjHQbgzRuB?h=bqPtExCfUeY4iYwAcxtc3UcDhTouwruYvgogozHywls=&u=https: > > //maven.apache.org/mailing-lists.html > > > > Kind regards > > Karl Heinz Marbaise > > Apache Maven PMC Chairman > > > > > > --------------------------------------------------------------------- > > To unsubscribe, e-mail: users-unsubscr...@maven.apache.org > > For additional commands, e-mail: users-h...@maven.apache.org > > > > This message is for information purposes only. It is not a > > recommendation, advice, offer or solicitation to buy or sell a product > > or service, nor an official confirmation of any transaction. It is > > directed at persons who are professionals and is intended for the > > recipient(s) only. It is not directed at retail customers. This message > is subject to the terms at: > > > https://clicktime.symantec.com/15sMvS6BcWbfo1YDQnReH?h=qQeTYV3le-OdLOQm017NuvphjZ_WxuzkH69ae-ifmzw=&u=https://www.cib.barclays/disclosures/web-and-email-disclaimer.html > . > > > > For important disclosures, please see: > > https://clicktime.symantec.com/15sMqbtu9tv5P4iHsE2Vf?h=RCZ7TALloq1Sdd7 > > ksGGigWQKNB2yoaC_iXzWu8V_lpQ=&u=https://www.cib.barclays/disclosures/s > > ales-and-trading-disclaimer.html regarding marketing commentary from > > Barclays Sales and/or Trading desks, who are active market > > participants; > > https://clicktime.symantec.com/15sMb7K3n3sJ9EEXEYq3o?h=IsbxNzO7vbbhmU4 > > p-rWTXeYqtzoeDmaxsxetovuVEgo=&u=https://www.cib.barclays/disclosures/b > > arclays-global-markets-disclosures.html > > regarding our standard terms for Barclays Corporate and Investment > > Bank where we trade with you in principal-to-principal wholesale > > markets transactions; and in respect to Barclays Research, including > > disclosures relating to specific issuers, see: > https://clicktime.symantec.com/15sLvTkn78QYqfd8t5drq?h=Z02PHAXBBgLb55eh0j-U1-p5vFfpDyPg5mVsshTm998=&u=http://publicresearch.barclays.com > . > > ______________________________________________________________________ > > ____________ > > > > If you are incorporated or operating in Australia, read these > > important > > disclosures: > > https://clicktime.symantec.com/15sMfwWLEfYtZB4Sn7ECR?h=FNdrtjdlz3tDT5S > > BusDGsBWFKuTJBuG11hzfudQYKgk=&u=https://www.cib.barclays/disclosures/i > > mportant-disclosures-asia-pacific.html > > . > > > > ______________________________________________________________________ > > ____________ For more details about how we use personal information, > > see our privacy > > notice: > https://clicktime.symantec.com/15sMkmhchHEUy7tNKfdM3?h=93NVNPx0KWrm2EXdoQwv85f_NMhfp4pL_PS3p3GjM88=&u=https://www.cib.barclays/disclosures/personal-information-use.html > . > > > > > > ______________________________________________________________________ > > ____________ > > This message is for information purposes only. It is not a recommendation, > advice, offer or solicitation to buy or sell a product or service, nor an > official confirmation of any transaction. It is directed at persons who are > professionals and is intended for the recipient(s) only. It is not directed > at retail customers. This message is subject to the terms at: > https://www.cib.barclays/disclosures/web-and-email-disclaimer.html. > > For important disclosures, please see: > https://www.cib.barclays/disclosures/sales-and-trading-disclaimer.html > regarding marketing commentary from Barclays Sales and/or Trading desks, > who are active market participants; > https://www.cib.barclays/disclosures/barclays-global-markets-disclosures.html > regarding our standard terms for Barclays Corporate and Investment Bank > where we trade with you in principal-to-principal wholesale markets > transactions; and in respect to Barclays Research, including disclosures > relating to specific issuers, see: http://publicresearch.barclays.com. > __________________________________________________________________________________ > > If you are incorporated or operating in Australia, read these important > disclosures: > https://www.cib.barclays/disclosures/important-disclosures-asia-pacific.html > . > > __________________________________________________________________________________ > For more details about how we use personal information, see our privacy > notice: https://www.cib.barclays/disclosures/personal-information-use.html. > > > __________________________________________________________________________________ > > --------------------------------------------------------------------- > To unsubscribe, e-mail: users-unsubscr...@maven.apache.org > For additional commands, e-mail: users-h...@maven.apache.org >
